Fig. 1From: Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational studyDisease activity based on CDAI at baseline and 6 months of biologic therapy. CDAI clinical disease activity index, LOCF last observation carried forward, IFX infliximab, TCZ tocilizumab, ABT abataceptBack to article page